Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.27−0.04 (-0.35%)
Close on Nov 17, 2026Market cap $249.12MP/E –Yield –
Amarin cash
Cash and short-term investments held at the end of each period.
Amarin's cash was $323.38M at Sep 30, 2026. For fiscal 2025 it was $302.59M, up 2.8% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is $644.59M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $302.59M | +2.8% |
| FY2024 | Dec 31, 2024 | $294.22M | -8.2% |
| FY2023 | Dec 31, 2023 | $320.66M | +3.7% |
| FY2022 | Dec 31, 2022 | $309.36M | -31.9% |
| FY2021 | Dec 31, 2021 | $454.13M | -9.3% |
| FY2020 | Dec 31, 2020 | $500.93M | -22.3% |
| FY2019 | Dec 31, 2019 | $644.59M | +158.6% |
| FY2018 | Dec 31, 2018 | $249.23M | +238.5% |
| FY2017 | Dec 31, 2017 | $73.64M | -25.5% |
| FY2016 | Dec 31, 2016 | $98.85M | -7.6% |
| FY2015 | Dec 31, 2015 | $106.96M | -10.5% |
| FY2014 | Dec 31, 2014 | $119.54M | -37.6% |
| FY2013 | Dec 31, 2013 | $191.51M | -26.4% |
| FY2012 | Dec 31, 2012 | $260.24M | +123.2% |
| FY2011 | Dec 31, 2011 | $116.60M | +270.8% |
| FY2010 | Dec 31, 2010 | $31.44M | -39.8% |
| FY2009 | Dec 31, 2009 | $52.26M | +267.0% |
| FY2008 | Dec 31, 2008 | $14.24M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $323.38M | +12.8% |
| Q2 FY2026 | Jun 30, 2026 | $314.65M | +5.3% |
| Q1 FY2026 | Mar 31, 2026 | $307.82M | +9.2% |
| Q4 FY2025 | Dec 31, 2025 | $302.59M | +2.8% |
| Q3 FY2025 | Sep 30, 2025 | $286.59M | -6.3% |
| Q2 FY2025 | Jun 30, 2025 | $298.70M | -2.6% |
| Q1 FY2025 | Mar 31, 2025 | $281.79M | -8.6% |
| Q4 FY2024 | Dec 31, 2024 | $294.22M | -8.2% |
| Q3 FY2024 | Sep 30, 2024 | $305.73M | -4.7% |
| Q2 FY2024 | Jun 30, 2024 | $306.66M | -2.0% |
| Q1 FY2024 | Mar 31, 2024 | $308.18M | +1.3% |
| Q4 FY2023 | Dec 31, 2023 | $320.66M | +3.7% |
| Q3 FY2023 | Sep 30, 2023 | $320.66M | +5.6% |
| Q2 FY2023 | Jun 30, 2023 | $312.91M | -0.1% |
| Q1 FY2023 | Mar 31, 2023 | $304.37M | -16.0% |
| Q4 FY2022 | Dec 31, 2022 | $309.36M | -31.9% |
| Q3 FY2022 | Sep 30, 2022 | $303.70M | -36.6% |
| Q2 FY2022 | Jun 30, 2022 | $313.23M | -38.5% |
| Q1 FY2022 | Mar 31, 2022 | $362.56M | -29.6% |
| Q4 FY2021 | Dec 31, 2021 | $454.13M | -9.3% |
| Q3 FY2021 | Sep 30, 2021 | $479.14M | -14.7% |
| Q2 FY2021 | Jun 30, 2021 | $508.93M | -7.5% |
| Q1 FY2021 | Mar 31, 2021 | $514.74M | -5.1% |
| Q4 FY2020 | Dec 31, 2020 | $500.93M | -22.3% |
| Q3 FY2020 | Sep 30, 2020 | $561.86M | -16.5% |
| Q2 FY2020 | Jun 30, 2020 | $550.28M | +148.1% |
| Q1 FY2020 | Mar 31, 2020 | $542.24M | +156.9% |
| Q4 FY2019 | Dec 31, 2019 | $644.59M | +158.6% |
| Q3 FY2019 | Sep 30, 2019 | $673.21M | +722.1% |
| Q2 FY2019 | Jun 30, 2019 | $221.77M | +116.9% |
| Q1 FY2019 | Mar 31, 2019 | $211.09M | +63.6% |
| Q4 FY2018 | Dec 31, 2018 | $249.23M | +238.5% |
| Q3 FY2018 | Sep 30, 2018 | $81.89M | +3.5% |
| Q2 FY2018 | Jun 30, 2018 | $102.26M | +19.6% |
| Q1 FY2018 | Mar 31, 2018 | $129.05M | +33.5% |
| Q4 FY2017 | Dec 31, 2017 | $73.64M | -25.5% |
| Q3 FY2017 | Sep 30, 2017 | $79.09M | – |
| Q2 FY2017 | Jun 30, 2017 | $85.46M | – |
| Q1 FY2017 | Mar 31, 2017 | $96.68M | – |
| Q4 FY2016 | Dec 31, 2016 | $98.85M | – |
See a number that looks wrong?